Testing metabolism in bladder cancer patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks how the body's energy use (metabolism) changes in bladder cancer patients receiving chemotherapy before bladder removal surgery. The goal is to better understand how treatment affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bladder cancer
- You are scheduled to get platinum-based chemotherapy before having your bladder removed
- Your heart and kidneys are healthy enough for this chemotherapy
- You have not had chemotherapy or radiation for bladder cancer before
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving chemotherapy before surgery to remove the bladder, to see if it can improve outcomes for patients with muscle-invasive bladder cancer. The treatment is personalized based on a lab test of your tumor cells, which may help make the therapy more effective.
This study is testing a new, non-invasive urine test that looks for specific DNA changes (methylation patterns) to find bladder cancer early. If you have bladder cancer or are a healthy person willing to help, you may be able to join.
This trial studies adding “heat treatment” (hyperthermia) to standard bladder cancer care using radiation, sometimes with chemotherapy. It may help the radiation work better, but your eligibility depends on cancer stage, your general health, and certain heart and metal-safety issues.
This trial tests a simple urine test to see if it can monitor prostate or bladder cancer without needing invasive procedures. It aims to find out if the test can track how well treatment is working.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.